New Product Increases T-Cell Count in HIV/AIDS Patients
CLAREMORE, OK-Ives Health Company has released a brief summary of the touted Java project.
The project was a landmark AIDS study carried out by Slayton-Beedeen, MD, an immunologist and founder of the product T-Factor. Slayton-Beedeed worked with the World Health Organization (WHO) in Jakarta and Bangkok, testing HIV positive patients of Asian descent with elevated HIV RNA and decreased CD-4 counts. They administered T-Factor and found that new hormonal inhibitors of HIV might initiate profound suppression of HIV replication.
They gave these HIV-positive patients the drug and found 80% experienced documented decreases in HIV RNA and enhanced CD-4 counts within 24 weeks.
T-Factor costs less than $3 per day, in comparison to other HIV drug therapies that cost an estimated $80 daily.
New studies of the product are taking place in the US and in Europe.
For more information about the company or T-Factor, visit www.iveshelath.com.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
A Helping Hand: Innovative Approaches to Expanding Hand Hygiene Programs in Acute Care Settings
July 9th 2025Who knew candy, UV lights, and a college kid in scrubs could double hand hygiene adherence? A Pennsylvania hospital’s creative shake-up of its infection prevention program shows that sometimes it takes more than soap to get hands clean—and keep them that way.
Broadening the Path: Diverse Educational Routes Into Infection Prevention Careers
July 4th 2025Once dominated by nurses, infection prevention now welcomes professionals from public health, lab science, and respiratory therapy—each bringing unique expertise that strengthens patient safety and IPC programs.
How Contaminated Is Your Stretcher? The Hidden Risks on Hospital Wheels
July 3rd 2025Despite routine disinfection, hospital surfaces, such as stretchers, remain reservoirs for harmful microbes, according to several recent studies. From high-touch areas to damaged mattresses and the effectiveness of antimicrobial coatings, researchers continue to uncover persistent risks in environmental hygiene, highlighting the critical need for innovative, continuous disinfection strategies in health care settings.
